These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 30257458)

  • 1. The Multifarious Functions of Pyruvate Kinase M2 in Oral Cancer Cells.
    Kurihara-Shimomura M; Sasahira T; Nakashima C; Kuniyasu H; Shimomura H; Kirita T
    Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30257458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of pyruvate kinase M2 associates with aggressive clinicopathological features and unfavorable prognosis in oral squamous cell carcinoma.
    Wang Y; Zhang X; Zhang Y; Zhu Y; Yuan C; Qi B; Zhang W; Wang D; Ding X; Wu H; Cheng J
    Cancer Biol Ther; 2015; 16(6):839-45. PubMed ID: 25970228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dietary-phytochemical mediated reversion of cancer-specific splicing inhibits Warburg effect in head and neck cancer.
    Yadav S; Bhagat SD; Gupta A; Samaiya A; Srivastava A; Shukla S
    BMC Cancer; 2019 Nov; 19(1):1031. PubMed ID: 31675998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of cancer metabolism-related proteins with oral carcinogenesis - indications for chemoprevention and metabolic sensitizing of oral squamous cell carcinoma?
    Grimm M; Cetindis M; Lehmann M; Biegner T; Munz A; Teriete P; Kraut W; Reinert S
    J Transl Med; 2014 Jul; 12():208. PubMed ID: 25048361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SRSF3, a Splicer of the PKM Gene, Regulates Cell Growth and Maintenance of Cancer-Specific Energy Metabolism in Colon Cancer Cells.
    Kuranaga Y; Sugito N; Shinohara H; Tsujino T; Taniguchi K; Komura K; Ito Y; Soga T; Akao Y
    Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30279379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations in glucose metabolism proteins responsible for the Warburg effect in esophageal squamous cell carcinoma.
    de Andrade Barreto E; de Souza Santos PT; Bergmann A; de Oliveira IM; Wernersbach Pinto L; Blanco T; Rossini A; Pinto Kruel CD; Mattos Albano R; Ribeiro Pinto LF
    Exp Mol Pathol; 2016 Aug; 101(1):66-73. PubMed ID: 27260309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isoform switch of pyruvate kinase M1 indeed occurs but not to pyruvate kinase M2 in human tumorigenesis.
    Zhan C; Yan L; Wang L; Ma J; Jiang W; Zhang Y; Shi Y; Wang Q
    PLoS One; 2015; 10(3):e0118663. PubMed ID: 25738776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PKM2 enhances cancer invasion via ETS-1-dependent induction of matrix metalloproteinase in oral squamous cell carcinoma cells.
    Park YJ; Kim JY; Lee DY; Zhang X; Bazarsad S; Chung WY; Kim J
    PLoS One; 2019; 14(5):e0216661. PubMed ID: 31071178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malic Enzyme 1 Is Associated with Tumor Budding in Oral Squamous Cell Carcinomas.
    Nakashima C; Kirita T; Yamamoto K; Mori S; Luo Y; Sasaki T; Fujii K; Ohmori H; Kawahara I; Mori T; Goto K; Kishi S; Fujiwara-Tani R; Kuniyasu H
    Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32998265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glutaminolysis and carcinogenesis of oral squamous cell carcinoma.
    Cetindis M; Biegner T; Munz A; Teriete P; Reinert S; Grimm M
    Eur Arch Otorhinolaryngol; 2016 Feb; 273(2):495-503. PubMed ID: 25663193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HOXC6-mediated transcriptional activation of ENO2 promotes oral squamous cell carcinoma progression through the Warburg effect.
    Feng J; Fang J
    J Biochem Mol Toxicol; 2024 Jul; 38(7):e23752. PubMed ID: 38923759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue-specific isoform switch and DNA hypomethylation of the pyruvate kinase PKM gene in human cancers.
    Desai S; Ding M; Wang B; Lu Z; Zhao Q; Shaw K; Yung WK; Weinstein JN; Tan M; Yao J
    Oncotarget; 2014 Sep; 5(18):8202-10. PubMed ID: 24077665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pokemon proto-oncogene in oral cancer: potential role in the early phase of tumorigenesis.
    Sartini D; Lo Muzio L; Morganti S; Pozzi V; Di Ruscio G; Rocchetti R; Rubini C; Santarelli A; Emanuelli M
    Oral Dis; 2015 May; 21(4):462-9. PubMed ID: 25439053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HnRNP L is important for the expression of oncogene SRSF3 and oncogenic potential of oral squamous cell carcinoma cells.
    Jia R; Zhang S; Liu M; Zhang Y; Liu Y; Fan M; Guo J
    Sci Rep; 2016 Nov; 6():35976. PubMed ID: 27808105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-216a inhibits the growth and metastasis of oral squamous cell carcinoma by targeting eukaryotic translation initiation factor 4B.
    Li L; Ma HQ
    Mol Med Rep; 2015 Aug; 12(2):3156-62. PubMed ID: 25955794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-139-5p inhibits the tumorigenesis and progression of oral squamous carcinoma cells by targeting HOXA9.
    Wang K; Jin J; Ma T; Zhai H
    J Cell Mol Med; 2017 Dec; 21(12):3730-3740. PubMed ID: 28780773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No evidence for a shift in pyruvate kinase PKM1 to PKM2 expression during tumorigenesis.
    Bluemlein K; Grüning NM; Feichtinger RG; Lehrach H; Kofler B; Ralser M
    Oncotarget; 2011 May; 2(5):393-400. PubMed ID: 21789790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance.
    Su L; Wang Y; Xiao M; Lin Y; Yu L
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Oct; 110(4):484-91. PubMed ID: 20868995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of NLRP3 inflammasome in 5-fluorouracil resistance of oral squamous cell carcinoma.
    Feng X; Luo Q; Zhang H; Wang H; Chen W; Meng G; Chen F
    J Exp Clin Cancer Res; 2017 Jun; 36(1):81. PubMed ID: 28637493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Up-regulation of miR-187 modulates the advances of oral carcinoma by targeting BARX2 tumor suppressor.
    Lin SC; Kao SY; Chang JC; Liu YC; Yu EH; Tseng SH; Liu CJ; Chang KW
    Oncotarget; 2016 Sep; 7(38):61355-61365. PubMed ID: 27542258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.